
RDCA-DAP
News & Events
-
September 14, 2021
VIEW NOW | 2021 RDCA-DAP® Workshop
The Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®) is an FDA-funded initiative with the goal of accelerating therapy development across rare diseases. The platform serves as a centralized and standardized infrastructure to host and share rare diseases data, to support and accelerate rare disease innovation. View the RDCA-DAP 2021 Virtual Workshop and learn...... -
July 21, 2021
View Now | How RDCA-DAP Can Help Inform Optimal Trial Design in Progressive Rare Disease
When: July 21, 2021, 12 p.m. ET
Case Study: Northstar Ambulatory Assessment as an outcome assessment in Duchenne muscular dystrophy
Presenters: Varun Aggarwal, PhD, Director, Statistical and Mathematical Medicine, Quantitative Medicine; Kevin Krudys, PhD, Office of Clinical Pharmacology, FDA
RDCA-DAP team: Jeff Barrett, PhD, FCP, Senior Vice President, RDCA-DAP Lead; Alexandre Bétourné, PhD, PharmD, Scientific Director, RDCA-DAP
-
June 16, 2021
View Now | RDCA-DAP Webinar Series: Value of Integrated Data and Analytics in Rare Disease Drug Development
When: June 16, 2021, 12 p.m. ET
Case Study: Modeling disease progression in polycystic kidney disease to inform trial design
Presenters: Rhoda Muse, PhD, Scientist 1, Quantitative Medicine; Klaus Romero, MD, MS, FCP, Chief Science Officer and Executive Director of Clinical Pharmacology; Jackson Burton, PhD, Executive Director, Quantitative Medicine
RDCA-DAP Team: Jeff Barrett, PhD, FCP., Senior Vice President, RDCA-DAP Lead; Alexandre Bétourné, PhD, PharmD, Scientific Director, RDCA-DAP
-
May 19, 2021
View Now | Interpretation of novel biomarkers in related diseases through data interoperability in a pan-rare disease database
When: May 19, 2021, 12 p.m. ET
Example Disease: Polycystic kidney disease and kidney transplant
Presenters: Jagdeep Podichetty, PhD, Director, Predictive Analytics; Klaus Romero, MD, MS, FCP, Chief Science Officer and Executive Director of Clinical Pharmacology; Jackson Burton, PhD, Executive Director, Quantitative Medicine
RDCA-DAP Team: Jeff Barrett, PhD, FCP., Senior Vice President, RDCA-DAP Lead; Alexandre Bétourné, PhD, PharmD, Scientific Director, RDCA-DAP
-
April 21, 2021
View Now | RDCA-DAP: Searching, visualizing and exploring data in the RDCA-DAP platform to identify data of interest for advanced analysis
When: April 21, 2021, 12 p.m. ET
Example Disease: Friedreich’s ataxia
Presenters: Amanda Borens, MSc, Executive Director, Data Science, DCC; Vicki Theurer Crider, Sr. Project Manager, DCC; Kurt Michels, Data Analyst, Data Science